What’s driving the future of weight management and biotech innovation? In this episode of tech4sight, host Diana Daniels sits down with Glen Travers, a biotech entrepreneur and venture capitalist with over 30 years of groundbreaking experience. Glen has been at the forefront of revolutionary developments like oral insulin, GLP-1 therapies, and metabolic health solutions that are transforming healthcare as we know it.

💡Together, they explore:

💉 How GLP-1 therapies, like Ozempic, started as diabetes treatments and evolved into game-changing solutions for obesity and metabolic disorders.

🤖 The role of AI and quantum computing in accelerating biotech innovation and improving outcomes.

💸 Insights into the risks and opportunities of investing in biotech startups.

🔮 Predictions for the next 25 years in healthcare, including advancements in cancer treatments and metabolic diseases.

🩺 How interconnected health challenges—like obesity, diabetes, and cardiovascular issues—are being tackled with cutting-edge therapies.

🚨Glen’s advice for entrepreneurs entering the biotech industry.

🎧 Listen to “A Foresight for: Biotech’s Impact on Weight Management” now on Spotify and other platforms!

Where Future Leaders Gather. Embark on a journey of discovery as we explore the cutting-edge of business, telecommunications, technology, and innovation. Subscribe now and stay ahead of the curve!